Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients
Clinical trial NCT00052182 · COMPLETED
Trial details
- NCT number
- NCT00052182
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.